Pfizer sells $3.9b of stakes in Haleon
Haleon, British multinational consumer healthcare company, announced on Tuesday that its top shareholder, Pfizer,…
Browsing Tag
Pfizer Inc.
Pfizer to deliver cancer therapy after Seagen acquisition
Pfizer CEO, Albert Bourla, said on Monday that the huge firm will be able to deliver Seagen’s cancer therapy at an…
Pfizer in talks to buy Seagen for more than $30bln
U.S. pharmaceutical giant Pfizer Inc. is in early talks to buy drug making company Seagen Inc. and it has cited…
Pfizer to buy antibiotics business from AstraZeneca
Pharmaceutical company AstraZeneca (AZN.L) has agreed to sell its small molecule antibiotics business to Pfizer Inc…
Pfizer nears deal to acquire Medivation for close to $14 billion
Pfizer Inc (PFE.N) is in advanced talks to acquire U.S. cancer drug company Medivation Inc (MDVN.O) for close to…
Pfizer approaches Medivation about potential takeover
Pfizer Inc (PFE.N) has approached U.S. cancer drug maker Medivation Inc (MDVN.O) to express interest in an…
Pfizer-Allergan deal faces new U.S. inversion rules
The U.S. Treasury Department took new steps on Monday to curb tax-avoiding corporate "inversions," with the pending…
Pfizer, Allergan say combined drug pipeline ‘underappreciated’
The research chiefs of betrothed drugmakers Pfizer Inc (PFE.N) and Allergan (AGN.N) say the proposed combination of…
Pfizer raises U.S. prices for over 100 drugs on January 1
Pfizer Inc (PFE.N), which plans a $160-billion merger with Ireland-based Allergan Plc (AGN.N) to slash its U.S. tax…
Pfizer to buy Allergan for more than $150 billion
Pfizer Inc (PFE.N) secured formal board approval on Sunday for its acquisition of Botox maker Allergan Plc (AGN.N)…
Pfizer in merger talks with Botox-maker Allergan: WSJ
Pharmaceutical giant Pfizer Inc (PFE.N) recently approached Botox-maker Allergan Plc (AGN.N) to discuss what could…
India rejects patent on Pfizer’s arthritis drug
India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a…
AstraZeneca Forecasts Revenue of $45bn by 2023
U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive…
Nestle To Buy Pfizer Infant-Food Unit For $ 11.9 Bln
Nestle SA (NESN), the world’s biggest food company, agreed to buy Pfizer Inc. (PFE)’s infant-nutrition unit for…